經濟通串流版 ET Net IQ Streaming - ETF簡況 ETF Basic information

ProShares Ultra Nasdaq Biotechnology

基本資料

種類:	ETF
費用比率%:	0.95
資產淨值:	83.97
成立日期:	06/04/2010

分析

市值分佈:

53.76%
大市值

6.31%
中市值

2.60%
小市值

持股比例加總可能不達100%，原因包括ETF持有現金或衍生工具。

行業分佈

國家/地區分佈

投資組合

(更新時間： 07/03/2026 05:58)

總持有投資項目: 248

100%

10大 (31.38%)

代號	名稱	佔比% ▼	持有日期
ARVN	Arvinas	0.04	27/02/2026
PRME	Prime Medicine	0.04	27/02/2026
KALV	KalVista Pharmaceuticals	0.04	27/02/2026
JANX	Janux Therapeutics	0.04	27/02/2026
ANNX	Annexon	0.04	27/02/2026
PSNL	Personalis	0.04	27/02/2026
ESPR	Esperion Therapeutics	0.04	27/02/2026
BIOA	BioAge Labs Inc.	0.04	27/02/2026
MESO	Mesoblast Limited	0.04	27/02/2026
ZLAB	Zai Lab Limited	0.04	27/02/2026
CMPS	COMPASS Pathways Plc	0.03	27/02/2026
RIGL	Rigel Pharmaceuticals Inc	0.03	27/02/2026
ALLO	Allogene Therapeutics	0.03	27/02/2026
MGTX	MeiraGTx Holdings plc	0.03	27/02/2026
REPL	Replimune Group	0.03	27/02/2026
DSGN	Design Therapeutics	0.03	27/02/2026
NMRA	Neumora Therapeutics	0.03	27/02/2026
CRMD	CorMedix	0.03	27/02/2026
IRWD	Ironwood Pharmaceuticals	0.03	27/02/2026
FDMT	4D Molecular Therapeutics	0.03	27/02/2026

1 2 3 4 5 6 7 8 9 10 11 12 13

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.